Healthcare - Biotechnology - NASDAQ - IL
$ 0.4755
4.69 %
$ 39.8 M
Market Cap
-1.03
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
93.47%
EBIT
Estimate
29.49%
Net Income
Estimate
20.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioLineRx Ltd.
BLRX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BLRX
EBIT FORECAST
EBIT Forecast Chart BLRX
NET INCOME FORECAST
Net Income Chart BLRX